In a hypoxic tumor microenvironment, upregulated TET2 promotes IL6 gene expression in tumor cells, an effect that may involve the catalytical activity of dioxygenase since it is associated with the demethylation of IL6 promoter55. This evidence concerns the gene TET2 and neoplasm.